{
    "title": "114_hr6139",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Comprehensive Immunosuppressive Drug \nCoverage for Kidney Transplant Patients Act of 2016''.\n\nSEC. 2. MEDICARE ENTITLEMENT TO IMMUNOSUPPRESSIVE DRUGS FOR KIDNEY \n              TRANSPLANT RECIPIENTS.\n\n    (a) Kidney Transplant Recipients.--Section 226A(b)(2) of the Social \nSecurity Act (42 U.S.C. 426-1(b)(2)) is amended by inserting ``(except \nfor eligibility for enrollment under part B solely for purposes of \ncoverage of immunosuppressive drugs described in section \n1861(s)(2)(J))'' before ``, with the thirty-sixth month''.\n    (b) Individuals Eligible Only for Coverage of Immunosuppressive \nDrugs.--\n            (1) In general.--Section 1836 of the Social Security Act \n        (42 U.S.C. 1395o) is amended--\n                    (A) by striking ``Every'' and inserting ``(a) In \n                General.--Every''; and\n                    (B) by inserting at the end the following new \n                subsection:\n    ``(b) Individuals Eligible for Immunosuppressive Drug Coverage.--\nBeginning on January 1, 2017, every individual whose insurance benefits \nunder part A has ended (whether before, on, or after such date) by \nreason of section 226A(b)(2) is eligible for enrollment in the \ninsurance program established by this part solely for purposes of \ncoverage of immunosuppressive drugs.''.\n            (2) Conforming amendment.--Sections 1837, 1838, and 1839 of \n        the Social Security Act (42 U.S.C. 1395(o), 42 U.S.C. 1395(p), \n        42 U.S.C. 1395(q)) are each amended by striking ``1836'' and \n        inserting ``1836(a)'' each place it appears.\n    (c) Enrollment for Individuals Only Eligible for Coverage of \nImmunosuppressive Drugs.--Section 1837 of the Social Security Act (42 \nU.S.C. 1395(p)) is amended by adding at the end the following new \nsubsection:\n    ``(m)(1) Any individual who is eligible under section 1836(b) to \nenroll in the medical insurance program established under this part for \npurposes of coverage of immunosuppressive drugs may enroll only in such \nmanner and form as may be prescribed by regulations, and only during an \nenrollment period described in this subsection.\n    ``(2) An individual described in paragraph (1) may enroll beginning \non the first day of the third month before the month in which the \nindividual first satisfies section 1836(b).\n    ``(3) An individual described in paragraph (1) whose entitlement \nfor hospital insurance benefits under part A ends by reason of section \n226A(b)(2) on or after January 1, 2017, shall be deemed to have \nenrolled in the medical insurance program established by this part for \npurposes of coverage of immunosuppressive drugs.''.\n    (d) Coverage Period for Individuals Only Eligible for Coverage of \nImmunosuppressive Drugs.--\n            (1) In general.--Section 1838 of the Social Security Act \n        (42 U.S.C. 1395(q)) is amended by adding at the end the \n        following new subsection:\n    ``(g) In the case of an individual described in section 1836(b), \nthe following rules shall apply:\n            ``(1) In the case of such an individual who is deemed to \n        have enrolled in part B for coverage of immunosuppressive drugs \n        under section 1837(m)(3), such individual's coverage period \n        shall begin on the first day of the month in which the \n        individual first satisfies section 1836(b).\n            ``(2) In the case of such an individual who enrolls in part \n        B for coverage of immunosuppressive drugs under section \n        1837(m)(2), such individual's coverage period shall begin on \n        the first day of the month in which the individual first \n        satisfies section 1836(b) or the month following the month in \n        which the individual so enrolls, whichever is later.\n            ``(3) The provisions of subsections (b) and (d) shall apply \n        with respect to an individual described in paragraph (1) or \n        (2).\n            ``(4) In addition to the reasons for termination under \n        subsection (b), the coverage period of an individual described \n        in paragraph (1) or (2) shall end when the individual becomes \n        entitled to benefits under this title under section 226(a), \n        226(b), or 226A.''.\n            (2) Conforming amendments.--Section 1838(b) is amended in \n        the matter following paragraph (2) by adding ``or section \n        1837(m)(3)'' after ``section 1837(f)'' each place it appears.\n    (e) Premiums for Individuals Only Eligible for Coverage of \nImmunosuppressive Drugs.--Section 1839 of the Social Security Act (42 \nU.S.C. 1395r) is amended--\n            (1) in subsection (b), by adding at the end the following \n        new sentence: ``No increase in the premium shall be effected \n        for individuals who are enrolled pursuant to section 1836(b) \n        for coverage only of immunosuppressive drugs.''; and\n            (2) by adding at the end the following new subsection:\n    ``(j) Determination of Premium for Individuals Only Eligible for \nCoverage of Immunosuppressive Drugs.--The Secretary shall, during \nSeptember of each year, determine and promulgate a monthly premium rate \nfor the succeeding calendar year for individuals who enroll only for \nthe purpose of coverage of immunosuppressive drugs under section \n1836(b). Such premium shall be equal to 35 percent of the monthly \nactuarial rate for enrollees age 65 and over, determined according to \nparagraph (1), for that succeeding calendar year. The monthly premium \nof each individual enrolled for coverage of immunosuppressive drugs \nunder section 1836(b) for each month shall be the amount promulgated in \nthis subsection. Such amount shall be adjusted in accordance with \nsubsections (c) and (f).''.\n    (f) Government Contribution.--Section 1844(a) of the Social \nSecurity Act (42 U.S.C. 1395(w)) is amended--\n            (1) in paragraph (3), by striking the period at the end and \n        inserting ``; plus'';\n            (2) by adding after paragraph (3) the following new \n        paragraph:\n            ``(4) a Government contribution equal to the estimated \n        aggregate reduction in premiums payable under part B that \n        results from establishing the premium at 35 percent of the \n        actuarial rate under section 1839(j) instead of 50 percent of \n        the actuarial rate for individuals who enroll only for the \n        purpose of coverage of immunosuppressive drugs under section \n        1836(b).''; and\n            (3) by adding at the end the following flush matter:\n        ``The Government contribution under paragraph (4) shall be \n        treated as premiums payable and deposited for purposes of \n        subparagraphs (A) and (B) of paragraph (1).''.\n    (g) Extension of Secondary Payer Requirements for ESRD \nBeneficiaries Eligible for Coverage of Immunosuppressive Drugs.--\nSection 1862(b)(1)(C) (42 U.S.C. 1395(y)(b)(1)) is amended by adding at \nthe end the following new sentence: ``With regard to immunosuppressive \ndrugs furnished to an individual who enrolls for the purpose of \ncoverage of immunosuppressive drugs under section 1836(b) on or after \nJanuary 1, 2017, this subparagraph shall apply without regard to any \ntime limitation, except that when such individual becomes entitled to \nbenefits under this title under sections 226(a) or 226(b), or entitled \nto or eligible for benefits under this title under section 226A, the \nprovisions of subparagraphs (A) and (B), and the time limitations under \nthis subparagraph, respectively, shall apply.''.\n    (h) Ensuring Coverage Under the Medicare Savings Program.--Section \n1905(p)(1)(A) of the Social Security Act (42 U.S.C. 1396d(p)(1)(A)) is \namended by inserting ``or an individual who is enrolled under part B \nfor the purpose of coverage of immunosuppressive drugs under section \n1836(b)'' after ``section 1818''.\n    (i) Part D.--Section 1860D-1(a)(3)(A) of the Social Security Act \n(42 U.S.C. 1395w-101(a)(3)(A)) is amended by inserting ``(but not \nincluding an individual enrolled solely for coverage of \nimmunosuppressive drugs under section 1836(b))'' before the period at \nthe end."
}